---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-26-000990"
form_type: "8-K/A"
ticker: "SBEV"
cik: "0001553788"
company_name: "SPLASH BEVERAGE GROUP, INC."
filed_at: "2026-07-30T20:10:52+00:00"
generated_at: "2026-07-30T20:12:06.904406+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Splash Beverage expands CannEpil license to veterinary therapeutics; royalty 10% on vet revenue

## Summary
- Expanded exclusive global license for CannEpil to include veterinary applications; royalty 10% of net revenue for vet, 15% for human.
- Initial focus on companion-animal oncology and chronic pain management; canine indications expected first.
- Global veterinary pain management market ~$2.6B in 2024, projected ~$3.8B by 2030; veterinary oncology market $900M-$1.7B.
- Company finalizing strategic joint venture with established cannabinoid pharmaceutical company to lead vet development.
- CannEpil is EU-GMP manufactured, has IND for human program; will pursue FDA Center for Veterinary Medicine pathways.

## SEC filing metadata
- accession: 0001731122-26-000990
- form_type: 8-K/A
- ticker: SBEV
- cik: 0001553788
- company_name: SPLASH BEVERAGE GROUP, INC.
- filed_at: 2026-07-30T20:10:52+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1553788/000173112226000990/0001731122-26-000990-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1553788/000173112226000990/e7816_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-26-000990
- JSON: https://secwatch.observer/filing/0001731122-26-000990.json
- Plain text: https://secwatch.observer/filing/0001731122-26-000990.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.